FDA Advisory Panel Votes Against Boosters For All

The Washington Post reports:

In an all-day FDA advisory meeting, experts resoundingly voted down Pfizer’s application for boosters for everyone 16 and older and is now debating whether to authorize an additional dose for older adults. The panelists may choose to green-light boosters for adults in older age brackets and with serious medical conditions that heighten their vulnerability to severe breakthrough disease.